Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

April 11, 2017

Primary Completion Date

July 20, 2020

Study Completion Date

July 20, 2020

Conditions
Small Bowel Crohn's Disease
Interventions
DRUG

Filgotinib

Tablet(s) administered orally once daily

DRUG

Placebo to match filgotinib

Tablet(s) administered orally once daily

Trial Locations (38)

1090

Medical University of Vienna, Department of Internal Medicine III, Division Gastroenterology and Hepatology, Vienna

2650

Universitair Ziekenhuis Antwerpen, Edegem

3200

Bugát Pál Kórház, Gasztroenterológiai osztály, Gyöngyös

4000

Centre Hospitalier Chretien, Liège

5600

Békés Megyei Központi Kórház Dr. Réthy Pál Tagkórháza, Békéscsaba

6020

Medical University of Innsbruck, Department of Internal Medicine I, Innsbruck

21045

Gastro Center of Maryland, Columbia

21742

Meritus Center for Clinical Research, Hagerstown

23249

McGuire DVAMC, Richmond

28942

Hospital Universitario de Fuenlabrada, Fuenlabrada

30625

Gastroenterologie, Hepatologie und Endokrinologie, Hanover

31059

CHU de Toulouse -Hopital Rangueil (Main Office), Toulouse

32804

Center for lnterventional Endoscopy- Florida Hospital, Orlando

33136

University of Miami Crohn's and Colitis Center, Miami

33606

University of South Florida South Tampa campus, Tampa

35016

Hospital Universitario Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria

38138

Gastro One, Germantown

46002

Communal Institution of Ternopil Regional Council Ternopil University Hospital. Regional Center of Gastroenterology, Ternopil

46202

Indiana University Health University Hospital, Indianapolis

48047

Clinical Research Institute of Michigan, Chesterfield

58103

Fargo Gastroenterology and Hepatology Clinic, Fargo

61137

Communal Healthcare Institution Regional Hospital of War Veterans, Department of Therapy #1, Kharkiv

66160

University of Kansas Medical Center, Kansas City

76012

Texas Clinical Research Institute, Arlington

76018

Ivano-Frankivsk Central City Clinical Hospital, Department of Therapy #1, SHEI Ivano-Frankivsk National Medical University, Ivano-Frankivsk

76092

Texas Digestive Disease Consultants, Southlake

78229

Gastroenterology Research of San Antonio, San Antonio

78666

TDDC San Marcos, San Marcos

88100

Azienda Ospedaliero - Universitaria Mater Domini, Catanzaro

M5T 3L9

Mount Sinai Hospital, Toronto

V8V 3M9

PerCuro Clinical Research Ltd., Victoria

500 12

Hepato-Gastroenterologie HK, s.r.o., Hradec Králové

07747

Universitatsklinikum Jena, Jena

00128

Gastroenterologia, Policlinico Universitario Campus Bio-Medico di Roma, Rome

G51 4TF

Queen Elizabeth University Hospital, Glasgow

EX2 5DW

Royal Devon and Exeter Hospital, Department of Gastroenterology, Exeter

SW17 0QT

St Georges Clinical Research Facility, London

OX3 9DU

John Radcliffe Hospital, Oxford

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Galapagos NV

INDUSTRY

lead

Gilead Sciences

INDUSTRY